Medical Bulletin 11/January/2024 Anshika Mishra11 Jan 2024 3:00 PM ISTHere are the top medical news of the day:Combining anti-tumor drugs with chemo may improve rare children’s cancer outcomesChildren who develop...
Severe MS predicted using machine learning Anshika Mishra11 Jan 2024 9:15 AM ISTA combination of only 11 proteins can predict long-term disability outcomes in multiple sclerosis (MS) for different individuals. The identified...
Individuals with pre-existing neurological diseases not prone to develop Long-COVID Dr Riya Dave10 Jan 2024 10:15 AM ISTA comprehensive retrospective cohort study has shed light on the potential health implications of COVID-19 in individuals with pre-existing conditions...
CDSCO Panel Grants Novartis Protocol Amendment For Ofatumumab Dr. Divya Colin31 Dec 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CAMH develops potential new drug treatment for multiple sclerosis Dr. Kamal Kant Kohli14 Dec 2023 3:45 AM ISTCAMH-led pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis (MS). The results...
Medical Bulletin 09/December/2023 Roshni Dhar9 Dec 2023 3:00 PM ISTHere are the top medical news of the day:Young age at first menstrual cycle linked to heightened diabetes risk in mid-lifeStarting menstrual cycles at...
Depression, constipation, and urinary tract infections may precede MS diagnosis Roshni Dhar9 Dec 2023 9:30 AM ISTIn some diseases, the underlying processes can start years before a diagnosis is made. A new study finds that people who later develop multiple...
Merck KGaA multiple sclerosis drug fails in late-stage trials Ruchika Sharma7 Dec 2023 3:30 PM ISTFrankfurt: Merck KGaA's experimental multiple sclerosis (MS) drug missed the primary goal in highly anticipated late-stage trials, dealing a...
Novartis raises sales growth target to 5 percent a year through 2027 Ruchika Sharma28 Nov 2023 3:30 PM ISTFrankfurt: Novartis has dialled up its sales growth target to 5% per year until 2027, citing demand for innovative drugs after the spin off of...
Low-fat diet reduces fatigue in patients with multiple sclerosis Dr. Kamal Kant Kohli22 Nov 2023 7:30 PM ISTNew research from Oregon Health & Science University suggests that people with multiple sclerosis, or MS, could benefit from a low-fat diet to...
COVID-19 has no impact on progression of Multiple Sclerosis: BMJ Jacinthlyn Sylvia13 Nov 2023 11:15 AM ISTA comprehensive study investigated the aftermath of COVID-19 in individuals with multiple sclerosis (PwMS) and found reassuring evidence that the...
Roche receives USFDA Breakthrough Device Designation for Multiple Sclerosis test Elecsys NfL Ruchika Sharma10 Nov 2023 12:30 PM ISTElecsys NfL has the potential to help laboratories to scale MS testing on widely available, fully automated and standardised Roche cobas instruments...
